Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine

NC Gassen, GR Fries, AS Zannas, J Hartmann… - Science …, 2015 - science.org
Epigenetic processes, such as DNA methylation, and molecular chaperones, including
FK506-binding protein 51 (FKBP51), are independently implicated in stress-related mental …

[HTML][HTML] Pathogenesis and treatment of depression: role of diet in prevention and therapy

W Mrozek, J Socha, K Sidorowicz, A Skrok, A Syrytczyk… - Nutrition, 2023 - Elsevier
In recent years, there has been a significant increase in depression, which is related to,
among other things, the COVID-19 pandemic. Depression can be fatal if not treated or if …

[HTML][HTML] Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK

C De las Cuevas, EJ Sanz, JA Gross, CU Correll… - Schizophrenia …, 2024 - Elsevier
Background Pharmacovigilance studies indicate clozapine history is marked by adverse
drug reactions (ADRs). Objective In a 2021 article, the United Kingdom (UK) had> 90% of …

Therapeutic reference ranges for psychotropic drugs: a protocol for systematic reviews

XM Hart, L Eichentopf, X Lense, T Riemer… - Frontiers in …, 2021 - frontiersin.org
Background: For many psychotropic drugs, monitoring of drug concentrations in the blood
(Therapeutic Drug Monitoring; TDM) has been proven useful to individualize treatments and …

Mechanisms of antidepressant resistance

W El-Hage, S Leman, V Camus… - Frontiers in …, 2013 - frontiersin.org
Depression is one of the most frequent and severe mental disorder. Since the discovery of
antidepressant (AD) properties of the imipramine and then after of other tricyclic compounds …

Novel treatment options in depression and psychosis

E Ceskova, P Silhan - Neuropsychiatric disease and treatment, 2018 - Taylor & Francis
In spite of tremendous development in central nervous system research, current treatment is
suboptimal, especially in severe mental disorders. In medicine, there are two main methods …

Pharmacogenetics and outcome with antipsychotic drugs

JG Pouget, TA Shams, AK Tiwari… - Dialogues in Clinical …, 2014 - Taylor & Francis
Antipsychotic medications are the gold-standard treatment for schizophrenia, and are often
prescribed for other mental conditions. However, the efficacy and side-effect profiles of these …

[HTML][HTML] Chronic and treatment resistant depression: diagnosis and stepwise therapy

T Bschor, M Bauer, M Adli - Deutsches Ärzteblatt International, 2014 - ncbi.nlm.nih.gov
Chronic and Treatment Resistant Depression - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Treatment with antipsychotics in pregnancy: changes in drug disposition

AA Westin, M Brekke, E Molden… - Clinical …, 2018 - Wiley Online Library
Although pregnancy is known to cause changes in drug pharmacokinetics, little is known
about its impact on serum levels of antipsychotics. In this study we retrospectively assessed …

Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?

G Remington, O Agid, G Foussias, L Ferguson… - …, 2013 - Springer
Rationale Clozapine levels are advocated in the monitoring of patients on this drug and
have now been used for a number of years. A safety-related threshold has also been …